Skip to main content
TipRanks
Go Ultimate75% OFF

Japan Medical Dynamic Marketing, Inc. (7600) AI Stock Analysis

0 Followers
JP:7600

Japan Medical Dynamic Marketing, Inc.

(TSE/TYO:7600)

Select Model
Rating:37Underperform
Price Target:JPY 299.00â–¼(-6.56% Downside)
Action:reiterated
Date:11/07/26

The stock scores at the absolute minimum of 37, reflecting a convergence of severe risks. The most significant factor is the extremely poor financial performance, marked by collapsing cash flows and declining profitability. This is compounded by a deeply bearish technical trend and a negative P/E ratio, leaving no fundamental or momentum-based support for the stock.

Positive Factors
Moderate LeverageA large equity base and moderate leverage provide financial flexibility as the company manages weaker recent profitability. Debt remains reasonable relative to equity, which can help preserve borrowing capacity and support operations or investment if financial performance stabilizes.
Negative Factors
Negative Free Cash FlowDeeply negative free cash flow reduces internally generated funding and can increase reliance on balance-sheet resources or external financing. The deterioration is especially concerning because operating cash flow was only about 0.03 times net income, indicating weak recent cash conversion.

Japan Medical Dynamic Marketing, Inc. (7600) vs. iShares MSCI Japan ETF (EWJ)

-50%-25%0%25%50%75%100%125%JP:7600-32.30%EWJ+16.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 8.43B
Dividend Yield
5.31%
Average Volume (3M)
366.80K
Price to Earnings (P/E)
-5.3
Beta (1Y)
1.07
Revenue Growth
-8.68%
EPS Growth
-75.03%
Country
Japan
Employees
539
Sector
General
Sector Strength
55
Industry
Medical - Devices

Japan Medical Dynamic Marketing, Inc. Business Overview & Revenue Model

Company Description

Japan Medical Dynamic Marketing, Inc. (JMDM) engages in the development, production, importation, and distribution of medical instruments throughout Japan and the United States. Its product portfolio features a variety of trauma devices, including su...

How the Company Makes Money

The company primarily generates revenue through the sale and distribution of medical devices and related healthcare products to customers such as hospitals, clinics, and other medical institutions. Revenue is typically recognized from product sales (...

Japan Medical Dynamic Marketing, Inc. Financial Statement Overview

Summary

Financial health is severely strained. Revenue is declining, margins have collapsed, and cash flow is deeply negative with free cash flow at -Â¥1.76 billion. The income statement and cash flow scores are critically low, offsetting a still-manageable balance sheet.

Income Statement

30Negative

Balance Sheet

42Neutral

Cash Flow

18Very Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue23.32B23.92B25.11B23.18B21.31B19.19B
Gross Profit12.00B12.74B15.65B14.76B13.99B12.99B
EBITDA1.62B2.19B1.40B3.27B3.35B4.21B
Net Income-220.55M263.14M-461.80M1.27B1.42B2.14B
Balance Sheet
Total Assets35.38B35.68B33.83B31.49B29.43B27.34B
Cash, Cash Equivalents and Short-Term Investments2.56B3.11B3.18B2.32B2.80B2.59B
Total Debt6.63B5.87B3.29B1.49B1.87B1.85B
Total Liabilities10.55B10.25B9.09B5.88B6.14B5.85B
Stockholders Equity24.81B25.40B24.68B25.51B23.16B21.39B
Cash Flow
Free Cash Flow0-1.75B-504.10M302.45M870.67M1.53B
Operating Cash Flow0205.55M1.05B2.10B2.19B3.11B
Investing Cash Flow0-2.00B-1.67B-1.80B-1.48B-1.75B
Financing Cash Flow01.65B1.49B-840.71M-514.78M-1.29B

Japan Medical Dynamic Marketing, Inc. Technical Analysis

Technical Analysis SentimentNegative
Last Price320.00

Price Trends

50DMA591.74Negative
100DMA741.89Negative
200DMA669.16Negative

Market Momentum

MACD-87.86Positive
RSI14.87Positive
STOCH6.26Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7600, the sentiment is Negative. The current price of 320.00 is below the 20-day moving average (MA) of 506.70, below the 50-day MA of 591.74, and below the 200-day MA of 669.16, indicating a bearish trend. The MACD of -87.86 indicates Positive momentum. The RSI at 14.87 is Positive, neither overbought nor oversold. The STOCH value of 6.26 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7600.

Japan Medical Dynamic Marketing, Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:7600 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:6678JP:667882OutperformJPY 18.47B12.52―5.95%17.11%23.02%
JP:6849JP:684963NeutralJPY 248.62B20.90―2.11%-0.18%-33.38%
JP:6523JP:652361NeutralJPY 156.61B10.998.71%3.41%2.74%145.33%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:4549JP:454950NeutralJPY 74.18B40.30―2.58%3.92%-52.01%
JP:7779JP:777948NeutralJPY 38.21B279.690.34%―-7.45%―
JP:7600JP:760037UnderperformJPY 8.43B-5.28―5.31%-8.68%-75.03%

* General Sector Average

Performance Comparison

0%50%100%JP:7600JP:7779JP:6523JP:4549JP:6678JP:6849Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7600 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7600Japan Medical Dynamic Marketing, Inc.320.00-162.41-33.67%
JP:7779CYBERDYNE 181.0015.009.04%
JP:6523PHC Holdings Corp.1230.00311.9333.98%
JP:4549Eiken Chemical Co., Ltd.2250.00-71.60-3.08%
JP:6678Techno Medica Co., Ltd.2167.00284.9515.14%
JP:6849Nihon Kohden Corporation1516.50-29.11-1.88%

Japan Medical Dynamic Marketing, Inc. Corporate Events

Japan Medical Dynamic Marketing Outlines First-Half Results Briefing Agenda

Nov 12, 2026

Japan Medical Dynamic Marketing, Inc. provided an agenda for its financial results briefing covering the interim period of the fiscal year ending March 2027. The agenda covers first-half consolidated sales and income, product-category sales reviews i...

Japan Medical Marketing Announces Management Cuts and Business Improvement Plan

Nov 4, 2026

Japan Medical Dynamic Marketing operates in the orthopedic medical-device industry, supplying trauma and spine products in Japan and the United States. Its market focus includes priority customers, new product adoption and recovery of procedure volum...

Japan Medical Dynamic Marketing Reports Interim Loss and Withdraws Dividend

Nov 4, 2026

Japan Medical Dynamic Marketing is a medical-device company focused on orthopedic products, including joint-replacement systems, with operations in Japan and the United States. Its business is exposed to hospital adoption trends, product competitiven...

Japan Medical Dynamic Marketing Swings to Interim Loss as Sales Decline

Nov 4, 2026

Japan Medical Dynamic Marketing, Inc. is a Tokyo-listed medical-device marketing company, although the release does not detail its product portfolio or market focus. For the six months ended September 30, 2026, consolidated sales fell 10.1% year over...

Japan Medical Dynamic Marketing Cuts U.S. Workforce to Bolster Profitability

Oct 15, 2026

Japan Medical Dynamic Marketing, Inc. has launched cost-cutting measures at its U.S. subsidiary Ortho Development Corporation, driven by declining net sales and the need to strengthen its earnings base. The subsidiary will undergo an organizational r...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 06, 2026